News Summary

Calgary-based healthtech startup RetinaLogik has successfully closed a $1.1 million CAD convertible note financing round and has obtained a Class II medical device license from Health Canada for its portable eye test product. This approval marks a significant milestone for RetinaLogik, enabling it to expand beyond screening into diagnostics and monitoring, and smooth its path for international growth. Founded in 2021 by Abdullah Sarhan and Julia St.Amand, RetinaLogik aims to enhance access to vision care and improve clinic efficiency using a VR, AI, and hardware-powered platform. The startup plans to use the new financing to improve its platform and accelerate expansion in North America. RetinaLogik has already registered with the US FDA and expanded its presence in eye care clinics across Canada and the US.